NEWARK, Del.–(EMWNews)–Dr. LingSing K. Chen has been chosen to head the new Translational

Medicine department at QPS, a leading provider of research services for

the pharmaceutical industry.

“In its Critical Path Initiative, the FDA

identified — correctly, we believe —

the need for this country to make significant improvements to the

process under which new drugs are developed,”

said Dr. Ben Chien, QPS president and CEO. “By

adding a department of Translational Medicine, we hope to play an

integral role in the process of moving research discoveries from the

laboratory into clinical practice more rapidly.”

Translational medicine is a relatively recent scientific discipline that

refers to the “translation” of basic research into real therapies for

patients. Since the emphasis is on a seamless linkage between the

laboratory and the patient, the practice is often referred to as “bench

to bedside” research.

“The remarkable growth in our biomarkers

business areas led us to consider this path,”

Dr. Chien said. “QPS considers the creation of

a Translational Medicine department pivotal to providing new

technologies to support preclinical and clinical drug development

worldwide.” Chien noted that many QPS clients

have already formed Translational Medicine units to facilitate the

interaction between basic research and clinical medicine, particularly

in clinical trials.

Chien said QPS would combine two existing groups, Immunobiomarker and

Molecular Biology, to form the new department. Dr. LingSing K. Chen,

former executive director of the Molecular Biology group, will head QPS’

new Translational Medicine department.

“Dr. Chen is a founding member of our

Molecular Biology group and has established very diverse capabilities

within a short period of time,” Dr. Chien

said. “She is a determined leader with a

great deal of entrepreneurial spirit and I have every reason to believe

in the success of our new venture.”

Prior to joining QPS, Dr. Chen held executive positions at Wyeth

Pharmaceuticals and as a senior advisor to the Industrial Technology

Research Institute (ITRI) in Taiwan. Dr. Chen received her MA and PhD in

molecular biology from Princeton University and her BS in biology from

National Taiwan University.

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions